KLOROMIN Drug Patent Profile
✉ Email this page to a colleague
When do Kloromin patents expire, and when can generic versions of Kloromin launch?
Kloromin is a drug marketed by Halsey and is included in one NDA.
The generic ingredient in KLOROMIN is chlorpheniramine maleate. There are twenty-nine drug master file entries for this compound. Two suppliers are listed for this compound. Additional details are available on the chlorpheniramine maleate profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Kloromin
A generic version of KLOROMIN was approved as chlorpheniramine maleate by AVANTHI INC on May 13th, 2009.
AI Deep Research
Questions you can ask:
- What is the 5 year forecast for KLOROMIN?
- What are the global sales for KLOROMIN?
- What is Average Wholesale Price for KLOROMIN?
Summary for KLOROMIN
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Raw Ingredient (Bulk) Api Vendors: | 83 |
| Patent Applications: | 3,122 |
| DailyMed Link: | KLOROMIN at DailyMed |
US Patents and Regulatory Information for KLOROMIN
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Halsey | KLOROMIN | chlorpheniramine maleate | TABLET;ORAL | 083629-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
